CC
SER icon

Corsicana & Co’s Serina Therapeutics SER Stock Holding History

Corsicana & Co’s Portfolio SER Stock Details SER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
28
– – ﹤0.01% 209
2022
Q2 		$1K Hold
28
– – ﹤0.01% 211
2022
Q1 		$1K Hold
28
– – ﹤0.01% 212
2021
Q4 		$1K Hold
28
– – ﹤0.01% 209
2021
Q3 		$1K Buy
+28
New +$1.17K ﹤0.01% 210

Other funds holding SER

BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SWIG
Strategic Wealth Investment Group Louisville, Kentucky $788M AUM 14.6% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Corsicana & Co's SER Position: Q3 2022 in Review

Corsicana & Co held its Serina Therapeutics (SER) position steady in Q3 2022 at 28 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #209.

Corsicana & Co first reported a position in SER in Q3 2021 and has held it in 5 quarters since. 31 funds tracked by Wall St. Rank hold SER as of Q3 2022.

  • Corsicana & Co held 28 shares of Serina Therapeutics worth $1K as of Q3 2022.
  • Corsicana & Co left its Serina Therapeutics share count unchanged in Q3 2022.
  • Serina Therapeutics made up ﹤0.01% of Corsicana & Co's portfolio in Q3 2022, its #209 holding.
  • Corsicana & Co first reported a position in Serina Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • 31 funds tracked by Wall St. Rank held Serina Therapeutics as of Q3 2022.

Based on Corsicana & Co's 13F filing for Q3 2022, filed 14 Oct 2022.